Efficacy and Safety of Adalimumab After ...

Document type :
Article dans une revue scientifique
DOI :
10.1097/MPG.0000000000000713
PMID :
26000887
Permalink :
http://hdl.handle.net/20.500.12210/5199
Title :
Efficacy and Safety of Adalimumab After lnfliximab Failure in Pediatric Crohn Disease
Author(s) :
Fumery, Mathurin [Auteur]
Jacob, Anne [Auteur]
Sarter, Helene [Auteur]
Michaud, Laurent [Auteur]
Lille Inflammation Research International Center (LIRIC) - U995
Lille Inflammation Research International Center (LIRIC) - U995
Spyckerelle, Claire [Auteur]
Mouterde, Olivier [Auteur]
Savoye, Guillaume [Auteur]
Colombel, Jean-Frederic [Auteur]
Peyrin-Biroulet, Laurent [Auteur]
Gower, Corinne [Auteur]
Lille Inflammation Research International Center (LIRIC) - U995
Lille Inflammation Research International Center (LIRIC) - U995
Turck, Dominique [Auteur]
Lille Inflammation Research International Center (LIRIC) - U995
Lille Inflammation Research International Center (LIRIC) - U995
Journal title :
Journal of pediatric gastroenterology and nutrition
Abbreviated title :
J. Pediatr. Gastroenterol. Nutr.
Volume number :
60
Pages :
744-748
Publication date :
2015-06-01
ISSN :
0277-2116
Keyword(s) :
growth
pediatric-onset Crohn disease
population-based study
adalimumab
HAL domain(s) :
Sciences du Vivant [q-bio]
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Inserm
Université de Lille
CHU Lille
Collections :
Research team(s) :
Inflammatory digestive disease : pathophysiology and therapeutic targets developement
Nutritional modulation of inflammation and infection
IBD and environnemental factors : epidemiology and functional analyses
Submission date :
2019-03-01T14:58:54Z